Bedrosian Camille L bought AMLX
August 18, 2026 · Form 4 insider transaction
Bedrosian Camille L bought 22,807 shares of Amylyx Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
22,807
Price
$0.00
Total value
N/A
InsiderBedrosian Camille L
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateAugust 18, 2026
Filing dateAugust 20, 2026
Shares owned after288,092
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported shares are represented by performance share units, or PSUs, and were awarded upon the achievement of certain performance metrics. Shares subject to the PSU vested on August 18, 2026.